Agenda - PDCO agenda of the 23-26 April 2024 meeting
Submitted by Anonymous (not verified) on 23 April 2024 - 10:55
Agenda - PDCO agenda of the 23-26 April 2024 meeting
Agenda of the CHMP meeting 22-25 April 2024
Submitted by Anonymous (not verified) on 23 April 2024 - 8:37
Agenda of the CHMP meeting 22-25 April 2024
Human medicines European public assessment report (EPAR): Lunsumio, mosunetuzumab, Date of authorisation: 03/06/2022, Revision: 4, Status: Authorised
Submitted by Anonymous (not verified) on 22 April 2024 - 15:31
Human medicines European public assessment report (EPAR): Lunsumio, mosunetuzumab, Date of authorisation: 03/06/2022, Revision: 4, Status: Authorised
List of medicinal products under additional monitoring
Submitted by Anonymous (not verified) on 22 April 2024 - 15:01
List of medicinal products under additional monitoring
List of medicinal products under additional monitoring
Submitted by Anonymous (not verified) on 22 April 2024 - 15:01
List of medicinal products under additional monitoring
Human medicines European public assessment report (EPAR): Lorviqua, lorlatinib, Date of authorisation: 06/05/2019, Revision: 13, Status: Authorised
Submitted by Anonymous (not verified) on 22 April 2024 - 15:00
Human medicines European public assessment report (EPAR): Lorviqua, lorlatinib, Date of authorisation: 06/05/2019, Revision: 13, Status: Authorised
Joint HMA/EMA Big Data Steering Group workshop on RWE methods, Online, European Medicines Agency, Amsterdam, the Netherlands, 14 June 2024
Submitted by Anonymous (not verified) on 22 April 2024 - 14:46
Joint HMA/EMA Big Data Steering Group workshop on RWE methods, Online, European Medicines Agency, Amsterdam, the Netherlands, 14 June 2024
Agenda - Joint HMA/EMA Big Data Steering Group Workshop on RWE methods
Submitted by Anonymous (not verified) on 22 April 2024 - 14:43
Agenda - Joint HMA/EMA Big Data Steering Group Workshop on RWE methods
List of medicines under additional monitoring
Submitted by Anonymous (not verified) on 22 April 2024 - 14:38
List of medicines under additional monitoring
Human medicines European public assessment report (EPAR): Jentadueto, linagliptin,metformin hydrochloride, Date of authorisation: 19/07/2012, Revision: 22, Status: Authorised
Submitted by Anonymous (not verified) on 22 April 2024 - 13:18
Human medicines European public assessment report (EPAR): Jentadueto, linagliptin,metformin hydrochloride, Date of authorisation: 19/07/2012, Revision: 22, Status: Authorised